• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis.

作者信息

Naser Moghadasi Abdorreza

机构信息

Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Autoimmun Rev. 2021 May;20(5):102803. doi: 10.1016/j.autrev.2021.102803. Epub 2021 Mar 16.

DOI:10.1016/j.autrev.2021.102803
PMID:33737090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7960029/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d2/7960029/88b9d186fbb9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d2/7960029/88b9d186fbb9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d2/7960029/88b9d186fbb9/gr1_lrg.jpg

相似文献

1
A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis.一名同时出现多发性硬化症和新冠肺炎临床症状的31岁女性患者：严重急性呼吸综合征冠状病毒2在多发性硬化症发病机制中的可能作用
Autoimmun Rev. 2021 May;20(5):102803. doi: 10.1016/j.autrev.2021.102803. Epub 2021 Mar 16.
2
[Vaccination against SARS-CoV-2 in patients with multiple sclerosis].[多发性硬化症患者的新型冠状病毒2型疫苗接种]
Rev Neurol. 2021 Apr 1;72(7):250-260. doi: 10.33588/rn.7207.2021097.
3
COVID-19 in a temporal relation to the onset of multiple sclerosis.与多发性硬化症发病存在时间关联的2019冠状病毒病
Mult Scler Relat Disord. 2021 May;50:102863. doi: 10.1016/j.msard.2021.102863. Epub 2021 Feb 24.
4
Multiple sclerosis following SARS-CoV-2 infection.感染 SARS-CoV-2 后出现多发性硬化症。
Mult Scler Relat Disord. 2020 Oct;45:102377. doi: 10.1016/j.msard.2020.102377. Epub 2020 Jul 7.
5
Encephalopathy associated with COVID-19 in a patient with multiple sclerosis.COVID-19 相关脑炎合并多发性硬化症患者
J Neurovirol. 2020 Dec;26(6):973-975. doi: 10.1007/s13365-020-00921-5. Epub 2020 Oct 28.
6
Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS.COVID-19 疫情对多发性硬化症患者免疫治疗的影响——从 SARS 和 MERS 中吸取的教训。
Front Immunol. 2020 May 12;11:1059. doi: 10.3389/fimmu.2020.01059. eCollection 2020.
7
COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.新型冠状病毒肺炎（COVID-19）mRNA 疫苗（辉瑞-生物科技和 Moderna）在多发性硬化症患者中的应用：波兰神经病学会多发性硬化症和神经免疫学分会召集的工作组的一份声明。
Neurol Neurochir Pol. 2021;55(1):8-11. doi: 10.5603/PJNNS.a2021.0016. Epub 2021 Feb 8.
8
Multiple sclerosis and COVID-19.多发性硬化症与2019冠状病毒病
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Sep;164(3):217-225. doi: 10.5507/bp.2020.033. Epub 2020 Jul 17.
9
Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide.用芬戈莫德和特立氟胺治疗的多发性硬化症患者中新冠病毒血清转化及病情进展缓慢情况
J Neurol Sci. 2020 Sep 15;416:117011. doi: 10.1016/j.jns.2020.117011. Epub 2020 Jul 4.
10
Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice. cladribine 治疗多发性硬化症的轻度或无 COVID-19 症状：两例病例及对临床实践的影响。
Mult Scler Relat Disord. 2020 Oct;45:102452. doi: 10.1016/j.msard.2020.102452. Epub 2020 Aug 16.

引用本文的文献

1
The impact of social and environmental factors on triggering multiple sclerosis onset, before and during the COVID-19 pandemic: a retrospective study from Iran.社会和环境因素对 COVID-19 大流行前后多发性硬化症发病的影响：来自伊朗的回顾性研究。
BMC Neurol. 2024 Nov 19;24(1):453. doi: 10.1186/s12883-024-03956-x.
2
Bilateral optic neuritis and encephalopathy as the atypical presentations of multiple sclerosis following severe acute respiratory syndrome coronavirus 2 infection.双侧视神经炎和脑病作为严重急性呼吸综合征冠状病毒2感染后多发性硬化症的非典型表现。
Taiwan J Ophthalmol. 2024 Jan 5;14(2):266-270. doi: 10.4103/tjo.TJO-D-23-00124. eCollection 2024 Apr-Jun.
3
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant?
新冠病毒疫苗接种前后的多发性硬化症发病：HLA单倍型能否成为决定因素？
Int J Mol Sci. 2024 Apr 22;25(8):4556. doi: 10.3390/ijms25084556.
4
Initial clinical presentation of multiple sclerosis with concurrent COVID-19 infection: Case report and literature review.多发性硬化症合并新型冠状病毒肺炎感染的初始临床表现：病例报告及文献综述
Curr J Neurol. 2022 Oct 7;21(4):251-255. doi: 10.18502/cjn.v21i4.11723.
5
Bioinformatics approach reveals the critical role of the NOD-like receptor signaling pathway in COVID-19-associated multiple sclerosis syndrome.生物信息学方法揭示了 NOD 样受体信号通路在 COVID-19 相关多发性硬化综合征中的关键作用。
J Neural Transm (Vienna). 2022 Aug;129(8):1031-1038. doi: 10.1007/s00702-022-02518-0. Epub 2022 Jun 1.
6
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum.COVID-19 大流行与抗中性粒细胞胞浆抗体相关性血管炎——EUVAS 会议和 EUVAS 教育论坛的报告。
Autoimmun Rev. 2021 Dec;20(12):102986. doi: 10.1016/j.autrev.2021.102986. Epub 2021 Oct 28.
7
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?多发性硬化症与 SARS-CoV-2：相互作用开始了吗？
Front Immunol. 2021 Sep 27;12:755333. doi: 10.3389/fimmu.2021.755333. eCollection 2021.
8
COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity?新型冠状病毒肺炎相关的中枢神经系统自身免疫性疾病（CRAD-C）：它是一种新的疾病实体吗？
Autoimmun Rev. 2021 Sep;20(9):102888. doi: 10.1016/j.autrev.2021.102888. Epub 2021 Jul 3.